ThinkSabio

$MBX

$67.08 119.79% YTD

7 SEC 13D/G filings tracked · Last updated Aug 14, 2026

Filing History
SEC 13D/G
MBX - MBX Biosciences, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified
$67.08 119.79%Aug 14, 2026 · ThinkSabio Blog

$MBX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #MBX MBX Biosciences, Inc. : $67.08 Sector: Healthcare | YTD: 🔼+

SEC 13D/G
MBX - MBX Biosciences, Inc. - SEC Filing Update (10-AUG-2026) | ThinkSabio - Stocks Simplified
$66.15 116.74%Aug 10, 2026 · ThinkSabio Blog

$MBX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #MBX MBX Biosciences, Inc. : $66.15 Sector: Healthcare | YTD: 🔼+

SEC 13D/G
MBX - MBX Biosciences, Inc. - SEC Filing Update (10-AUG-2026) | ThinkSabio - Stocks Simplified
$66.15 116.74%Aug 10, 2026 · ThinkSabio Blog

$MBX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #MBX MBX Biosciences, Inc. : $66.15 Sector: Healthcare | YTD: 🔼+

SEC 13D/G
$MBX SEC Filing Update (29-JUL-2026) | ThinkSabio - Stocks Simplified
$63.96 109.57%Jul 29, 2026 · ThinkSabio Blog

$MBX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #MBX : $63.96 Sector: Healthcare | YTD: 🔼+ 109.57% The SEC disclo

SEC 13D/G
$MBX SEC Filing Update (08-JUL-2026) | ThinkSabio - Stocks Simplified
$62.82 105.83%Jul 8, 2026 · ThinkSabio Blog

$MBX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #MBX : $62.82 Sector: Healthcare | YTD: 🔼+ 105.83% The SEC disclo

SEC 13D/G
$MBX SEC Filing Update (08-JUL-2026) | ThinkSabio - Stocks Simplified
$62.70 105.44%Jul 8, 2026 · ThinkSabio Blog

$MBX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #MBX : $62.70 Sector: Healthcare | YTD: 🔼+ 105.44% The SEC disclo

SEC 13D/G
$MBX SEC Filing Update (24-JUN-2026) | ThinkSabio - Stocks Simplified
$48.40 58.58%Jun 24, 2026 · ThinkSabio Blog

SEC Filing Update: #MBX : $48.40 Sector: Healthcare | YTD: 🔼+ 58.58% The SEC disclosed Today (24-JUN-2026) that Paradigm Biocapital Advisors LP has Ne